Glenview Trust Co Enters Amgen with $3 Million Stake
Glenview Trust Co has entered into a new position in Amgen Inc. (NASDAQ:AMGN) by purchasing 8,321 shares of the company's stock during the second quarter.
The institutional investor acquired the shares valued at approximately $3,013,000.
Amgen Inc. is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California, focusing on discovering, developing, manufacturing and delivering human therapeutics that address serious illnesses.